Abu Dhabi’s investment and holding company, ADQ, and UAE-based E20 Investment Limited (agribusiness investment company) partner to establish a new animal health platform in the emirate.
This agreement represents a landmark milestone for the region’s animal healthcare industry.
The animal health platform will initially comprise a cutting-edge animal vaccine manufacturing facility and a complex with two state-of-the-art animal hospitals.
“Leveraging our healthcare and life sciences expertise, we have identified an opportunity to create an adjacent platform in animal health,” said Fahad Al Qassim, executive director, Healthcare and Life Sciences Portfolio at ADQ.
“By creating a joint venture with E20, we will capitalize on Abu Dhabi’s strong market potential for animal vaccine production and maintaining the health and welfare of prized animals, such as horses and camels,” he added.
Once operational, the facilities will further enhance Abu Dhabi’s position as a regional leader in high-end veterinary services for horses and camels while producing the most technologically advanced animal vaccines serving the Middle East and Africa region.
“Together with ADQ, we will bring world-class vaccine technology to the UAE and join hands with our partner to foster local production and serve lucrative markets in the MENA region and beyond,” said Sultan Al Jaberi, CEO of E20 Investment Limited.
Earlier in April, ADQ signed an agreement to acquire a majority equity stake in Italy-based Unifrutti Group, a global producer and distributor of fresh produce including apples, bananas, cherries, grapes, and citrus fruits.
Since its establishment in 2018, ADQ’s investments span the various key sectors of the UAE’s diverse economy such as energy and utilities, food and agriculture, healthcare and life sciences, and mobility and logistics.
